2020
DOI: 10.1016/j.ymgmr.2020.100635
|View full text |Cite
|
Sign up to set email alerts
|

Behavioral, social and school functioning in children with Pompe disease

Abstract: Purpose To improve our understanding of the behavioral, social, and emotional functioning of children and adolescents with Pompe disease. Method Parents/guardians of 21 children (age 5-18y) with infantile (IPD) or late-onset (LOPD) Pompe disease on long-term enzyme replacement therapy completed three standardized checklists regarding their child's behavior: the Child Behavior Checklist (CBCL), Conners 3 Parent (Conners-3), Behavior Rating Inventory of Executive Function… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(11 citation statements)
references
References 17 publications
0
11
0
Order By: Relevance
“…For example, the neuropathic pain associated with Fabry disease and the skeletal symptoms associated with MPS impede pediatric patients’ ability to perform activities of daily living 42,44 . Further, it has been reported that pediatric patients with infantile Pompe disease experience more challenges in regard to activity and school competence when compared to peers of the same age 45 . Among adult patients with Gaucher disease, occupational and career choices are affected 32 .…”
Section: Discussionmentioning
confidence: 99%
“…For example, the neuropathic pain associated with Fabry disease and the skeletal symptoms associated with MPS impede pediatric patients’ ability to perform activities of daily living 42,44 . Further, it has been reported that pediatric patients with infantile Pompe disease experience more challenges in regard to activity and school competence when compared to peers of the same age 45 . Among adult patients with Gaucher disease, occupational and career choices are affected 32 .…”
Section: Discussionmentioning
confidence: 99%
“…Sanofi-Genzyme, Inc. using a rhGAA (alglucosidase alfa) secreted from a CHO cell line has demonstrated moderate success in patients (27), however yearly costs are very high. Although alglucosidase alfa has been a wonderful first step in treating PD it has revealed subtle aspects that must be dealt with for successful treatment (18,(42)(43)(44)(45)(46)(47)(48)(49). ERT usually begins when the patients are symptomatic, however, all the secondary problems are already present which are further compounded by issues with alglucosidase alfa uptake in muscle (Table 7) (18).…”
Section: Discussionmentioning
confidence: 99%
“…Gutschmidt et al (42) found that ERT in late onset patients' clinical outcomes, particularly lung function, muscle strength and walking capability tend to deteriorate over time, indicating that additional efforts must be made to improve ERT effectiveness and supplement therapies developed. Korlimarla et al (43) used a standardized behavior checklists as screening tools for the early identification and treatment of behavior, emotional and social concerns in children with PD. Although alglucosidase alfa has been a wonderful first step in treating people with PD, it has revealed subtle aspects that must be dealt with for successful treatment (18,(43)(44)(45)(46)(47)(48)(49).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Humans form their behavior through continuous reciprocal interactions between cognitive, behavioral and environmental influences (Jean-Claude, 2006). Behavior forms from what is instilled in early childhood through the environment, leading to the development of social behavior (Liu et al, 2020;Korlimarla et al, 2020). Behavior includes not only things that are overt but covert.…”
Section: Children's Social Behaviormentioning
confidence: 99%